Table 1 Clinical and demographic characteristics of the patients
From: IRAK-M has effects in regulation of lung epithelial inflammation
rs1624395/rs1370128 | AA/TT | AG/TC | GG/CC |
|---|---|---|---|
N | 35 | 78 | 24 |
Mean age (y) | 46.7 ± 16.4 | 45.1 ± 14.7 | 41.7 ± 14.7 |
Male, n (%) | 16 (45.7) | 24 (30.8) | 11 (45.8) |
Blood LnEos | 5.1 ± 2.1 | 4.3 ± 2.4 | 5.5 ± 0.7 |
Serum LnIgE | 4.2 ± 1.9 | 4.1 ± 2.3 | 5.5 ± 1.8 |
Pulmonary function measures | |||
FEV1 (L) | 2.1 ± 1.1 | 2.1 ± 1.1 | 2.4 ± 1.0 |
FVC (L) | 3.1 ± 1.5 | 2.8 ± 1.5 | 3.3 ± 1.3 |
FEV1% pred (%) | 65.6 ± 27.3 | 70.2 ± 36.8 | 71.7 ± 24.5 |
FEV1/FVC (%) | 59.5 ± 22.8 | 61.4 ± 29.0 | 66.3 ± 17.9 |
ICS, n (%) | 20 (57.1) | 50 (64.1) | 13 (54.2) |
CXCL10 (ng/ml) | 38.1 ± 3.3 | 41.6 ± 15.6 | 41.4 ± 7.8 |